Corrigendum

Neuro Oncol. 2021 Jul 1;23(7):1210. doi: 10.1093/neuonc/noy179.

N Cayuela¹, E Jaramillo-Jiménez², C Majós³, R Velasco¹, T Boget⁴, F Graus⁵, J Bruna⁶, M Simó^{1

7}

¹ Neuro-Oncology Unit, Hospital Universitari de Bellvitge-ICO l'Hospitalet, IDIBELL, Barcelona, Spain, Hospitalet de Llobregat, Spain.
² Neuro-Oncology Unit, Instituto Neurológico de Colombia (INDEC), Universidad CES, Medellín, Colombia, Medellín, Colombia.
³ Radiology, Institut Diagnòstic per la Imatge (IDI), L'Hospitalet de Llobregat, Barcelona, Spain, Hospitalet de Llobregat, Spain.
⁴ Epilepsy Unit, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Hospital Clinic de Barcelona, Barcelona, Spain, Barcelona, Spain.
⁵ Department of Neurology, IDIBAPS, Hospital Clínic, Barcelona, Spain, Barcelona, Spain.
⁶ Institute of Neurosciences, Department of Cell Biology, Physiology and Immunology, Universitat Autònoma de Barcelona, CIBERNED, Bellaterra, Spain, Bellaterra, Spain.
⁷ Cognition and Brain Plasticity Group, IDIBELL, Barcelona, Spain, Hospitalet de Llobregat, Spain.

No abstract available